Befejeződött4. fázis
Transfer of metformin into human breast milk and the plasma of breastfeeding children - A low intervention trial with biobanking of breast milk and plasma in Västra Götalandsregionen and Region Örebro
Key facts
- Where
- Gothenburg és Orebro, SvédországSee the 2 sites
- Phase
- 4. fázis
Where in Svédország
- Sahlgrenska University Hospital-Vastra GotalandsregionenGothenburg, SvédországNo longer taking part
- Region Oerebro LaenOrebro, SvédországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Uppsala Universitet
- Trial code
- EU 2022-501693-19-00
- Record updated
- 2024. november 19.
- Original description
The primary trial objective is to determine the concentration of metformin in plasma of breast fed infants of lactating women treated for Type 2 Diabetes.Read full original descriptionShow less
The primary trial objective is to determine the concentration of metformin in plasma of breast fed infants of lactating women treated for Type 2 Diabetes.
Inclusion: Breastfeeding women treated with metformin for suspected or diagnosed type 2 diabetes mellitus (T2DM). Only women of 18 years of age and older will be asked for participation. Breastfeeding children of women that have consented to participate in the study. The guardians of the child are asked for participation.
Exclusion: Previous participation in the study. Women not able to read and communicate in Swedish, Arabic, Persian or Somali. Premature children. Women with multiple births.